6 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
Follow Prostatic Hyperplasia: new trials by email Literature Review of Prostatic Hyperplasia trials Research Report on Prostatic Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Outcomes of MIST for BPH: A Single-Institution Prospective Study Rezum, iTind - Benign Prostatic Hyperplasia | Phase 3 | Unknown | University of Manitoba | 20 | 2024-03-01 | 2024-02-23 |
| Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH Prostatic Artery Embolization (PAE), Pharmacotherapy - Benign Prostatic Hyperplasia, Pharmacotherapy | Phase 3 | Unknown | Dominik Abt | 425 | 2021-09-01 | 2021-01-26 |
| PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia Prostate Artery Embolization, Sham Prostate Artery Embolization - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 3 | Unknown | Society of Interventional Radiology Foundation | 108 | 2021-08-01 | 2021-03-19 |
| Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH alpha-blocker or 5-ARI withdrawal, Maintenance of alpha-blocker and 5-ARI - Prostatic Hyperplasia, Prostate Hyperplasia | Phase 3 | Unknown | Gangnam Severance Hospital | 300 | 2020-12-08 | 2021-08-27 |
| The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction Tamsulosin 0.2mg, Tadalafil 5mg, Placebo for Tamsulosin - Benign Prostatic Hyperplasia, Erectile Dysfunction | Phase 3 | Unknown | IlDong Pharmaceutical Co Ltd | 330 | 2016-03-01 | 2016-08-12 |
| Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia Tamsulosin, Solifenacin, Solifenacin placebo - Benign Prostate Hyperplasia | Phase 3 | Unknown | IlDong Pharmaceutical Co Ltd | 588 | 2016-01-01 | 2016-07-13 |
Erectile Dysfunction (1) · Lower Urinary Tract Symptoms (1)
Genital Diseases (6) · Genital Diseases, Male (6) · Male Urogenital Diseases (6) · Prostatic Diseases (6) · Urogenital Diseases (6) · Mental Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Sexual Dysfunction, Physiological (1) · Sexual Dysfunctions, Psychological (1) · Signs and Symptoms (1) · Urological Manifestations (1)
Tamsulosin (2) · Adrenergic alpha-Antagonists (1) · Drug Therapy (1) · Solifenacin Succinate (1) · Tadalafil (1)
IlDong Pharmaceutical Co Ltd (2) · Dominik Abt (1) · Gangnam Severance Hospital (1) · Society of Interventional Radiology Foundation (1) · University of Manitoba (1)
South Korea (3) · Canada (1)
Dominik Abt, MD (1) · Jafar Golzarian, MD (1) · Kyo Chul Koo, MD, PhD (1) · Shamar Young, MD (1)